What Ebola and Marburg are teaching us about the next pandemic - Scorecard - MDSpire

What Ebola and Marburg are teaching us about the next pandemic

  • By

  • Krutika Kuppalli

  • Placide Mbala

  • July 1, 2026

  • 0 min

Share

Clinical Scorecard: Insights from Ebola and Marburg on Preparing for Future Pandemics

At a Glance

CategoryDetail
ConditionViral Hemorrhagic Fevers
Key MechanismsInability to rapidly diagnose pathogens due to reliance on pathogen-specific tests.
Target PopulationPatients presenting with symptoms of viral hemorrhagic fever.
Care SettingPublic health outbreak response

Key Highlights

  • Current diagnostic tools failed to detect Bundibugyo ebolavirus (BVD) during the outbreak.
  • Simultaneous circulation of multiple pathogens complicates outbreak response.
  • Need for pathogen-agnostic diagnostic systems to improve outbreak detection.

Guideline-Based Recommendations

Diagnosis

  • Develop deployable, validated diagnostic platforms for all known pathogenic filoviruses.

Management

  • Shift from pathogen-specific diagnostics to syndrome-based diagnostic approaches.

Monitoring & Follow-up

  • Implement surveillance systems capable of recognizing novel pathogens.

Risks

  • Assumptions about pathogen emergence and spread may lead to inadequate responses.

Patient & Prescribing Data

Individuals with symptoms of viral hemorrhagic fever.

Current treatments are limited due to lack of rapid and reliable diagnostics.

Clinical Best Practices

  • Invest in multiplex molecular diagnostics and metagenomic sequencing.
  • Utilize artificial intelligence-assisted surveillance for outbreak detection.

Related Resources & Content

    Original Source(s)

    What Ebola and Marburg are teaching us about the next pandemic

    • by Krutika Kuppalli, Placide Mbala

    • July 1, 2026

    Related Content

    Marburg outbreak is reported in Uganda, threatening to complicate Ebola response in region

    Medical Oddities: Prayer for Pain?

    This week’s research collection showed that biology, behavior, and environment often intersect in unexpected ways.

    When Bad Data Enters the Drug Pipeline

    Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.